Trastuzumab may lead to serious heart problems, including heart failure. The risk of heart problems is increased if you also use an anthracycline (e.g., doxorubicin). Your doctor may need to stop this medication if heart problems occur.
Trastuzumab use may sometimes result in a serious reaction to the IV infusion with serious lung problems. If these problems occur, they usually happen while the drug is being given...
Read moreQ. I’ve been diagnosed with HER2-positive stage II breast cancer, and after surgery will be doing chemo (AC + T). After that’s done, my... Read more »
About two years after I finished chemotherapy, surgery, and radiation to treat inflammatory breast cancer, I started having trouble with... Read more »
Q. I’m having TCH chemotherapy for breast cancer. What is it?A. The chemotherapy drugs Paclitaxel (Taxol) or docetaxel (Taxotere) and... Read more »
The annual San Antonio Breast Cancer Symposium (SABCS), held last month, is the premier scientific symposium in the world for breast... Read more »
Recently, I posted a blog entry on the high rates of cardiovascular disease among people with schizophrenia. A reader asked if... Read more »
Source: Breastcancer.org
Herceptin (chemical name: trastuzumab) is one of the first targeted therapies used to treat breast cancer. It specifically attacks, kills off, or... Read more »
Source: Breastcancer.org
Herceptin causes flu-like symptoms in about 40% of the people who take it. These symptoms may include: fever chills muscle aches nausea Side... Read more »
Source: Breastcancer.org
If you're having heart problems you may feel that your heart is beating irregularly, very fast, or forcefully in your chest. You may have chest pains... Read more »
Source: Breastcancer.org
Brand name: Herceptin Chemical name: Trastuzumab Class: HER2 (human epidermal receptor 2) inhibitor targeted therapy. Tykerb is another HER2... Read more »
A combination of the breast cancer drugs Herceptin and Tykerb may slow the progression of the disease, a recent study suggests. In a study of 300... Read more »